Evidence Watch

EVIDENCE IN CONTEXT | FDA generative AI-enabled medical devices: what the 2026 discussion paper means for healthcare governance · 20 Aug 2026 WHO | Mental-health access to expand in Jordan and Nepal through community, district-hospital and school-based services · 14 Aug 2026 JAMA HEALTH FORUM | Real-time prescription benefit tools improved fills for the highest-cost medicines, particularly in lower-income communities, but not overall · 14 Aug 2026 WHO | New HEARTS compendium standardizes hypertension-programme terminology, indicators and continuity-of-care measurement · 13 Aug 2026 NATURE MEDICINE | Genomic analysis indicates the 2026 Bundibugyo outbreak arose from a new zoonotic spillover rather than resurgence of earlier variants · 10 Aug 2026 WHO | Ervebo prioritized for Phase 3 research in the Bundibugyo outbreak while a strain-specific vaccine remains unavailable · 7 Aug 2026 NATURE MEDICINE | Multi-turn simulated audits found mental-health chatbot risks can accumulate and vary by psychological vulnerability · 7 Aug 2026 JAMA HEALTH FORUM | Mandatory value-based payment participation was associated with more than US$3 billion in additional annual hospital administrative costs · 7 Aug 2026 JAMA HEALTH FORUM | More than one-third of 193 high-risk therapeutic devices experienced serious recalls, strengthening the case for robust post-market surveillance · 7 Aug 2026 WHO | Health financing under pressure: urgent action needed to sustain essential services and universal health coverage · 28 Jul 2026 NATURE MEDICINE | Retina4IRD assistance raised top-five genetic-category accuracy from 67.3% to 88.5% in a multicentre randomized trial · 24 Jul 2026 SCIENCE CORPORATION | PRIMA retinal implant receives EU MDR CE mark for form-vision restoration in geographic atrophy due to AMD · 22 Jul 2026

EVIDENCE IN CONTEXT | FDA generative AI-enabled medical devices: what the 2026 discussion paper means for healthcare governance · 20 Aug 2026 WHO | Mental-health access to expand in Jordan and Nepal through community, district-hospital and school-based services · 14 Aug 2026 JAMA HEALTH FORUM | Real-time prescription benefit tools improved fills for the highest-cost medicines, particularly in lower-income communities, but not overall · 14 Aug 2026 WHO | New HEARTS compendium standardizes hypertension-programme terminology, indicators and continuity-of-care measurement · 13 Aug 2026 NATURE MEDICINE | Genomic analysis indicates the 2026 Bundibugyo outbreak arose from a new zoonotic spillover rather than resurgence of earlier variants · 10 Aug 2026 WHO | Ervebo prioritized for Phase 3 research in the Bundibugyo outbreak while a strain-specific vaccine remains unavailable · 7 Aug 2026 NATURE MEDICINE | Multi-turn simulated audits found mental-health chatbot risks can accumulate and vary by psychological vulnerability · 7 Aug 2026 JAMA HEALTH FORUM | Mandatory value-based payment participation was associated with more than US$3 billion in additional annual hospital administrative costs · 7 Aug 2026 JAMA HEALTH FORUM | More than one-third of 193 high-risk therapeutic devices experienced serious recalls, strengthening the case for robust post-market surveillance · 7 Aug 2026 WHO | Health financing under pressure: urgent action needed to sustain essential services and universal health coverage · 28 Jul 2026 NATURE MEDICINE | Retina4IRD assistance raised top-five genetic-category accuracy from 67.3% to 88.5% in a multicentre randomized trial · 24 Jul 2026 SCIENCE CORPORATION | PRIMA retinal implant receives EU MDR CE mark for form-vision restoration in geographic atrophy due to AMD · 22 Jul 2026

Dr. Samer Al-Diri

MD, MSc, MPH • UK-trained ophthalmologist Healthcare management, public health, strategy, quality and governance

Flagship Reference Publications

Healthcare management in ophthalmology infographic by Dr. Samer Al-Diri highlighting patient benefit, financial viability and equitable access.

September 7, 2026 • Eye Health • Healthcare Management

Healthcare Management in Ophthalmology: The Economics of Better Care

Dr. Samer Al-Diri examines how ophthalmology leaders can align AI investment, care delivery and payment with patient benefit and financial sustainability.

Read More →

Five-domain eye-care framework for health-system performance covering capacity, equity, continuity, digital assurance and outcomes — Dr Samer Al-Diri

August 31, 2026 • Eye Health • Healthcare Management • Public Health

Reading Health-System Performance Through Eye Care

A five-domain executive framework for capacity, equity, continuity, digital assurance and outcomes By Dr Samer Al-Diri Dr Samer Al-Diri,...

Read More →

Healthcare Partnership Governance featured image by Dr Samer Al-Diri on strategic alliances, outsourced services and clinical accountability

August 24, 2026 • Healthcare Management

Healthcare Partnership Governance: Aligning Strategic Alliances, Outsourced Services and Clinical Accountability

Healthcare partnerships can expand access, expertise and capacity, but they also create accountability risks across organisational boundaries. Dr Samer Al-Diri presents a Five-Interface Partnership Governance Model and seven-question executive test for governing strategic alliances and outsourced healthcare services.

Read More →

FDA generative AI-enabled medical devices and healthcare governance – Dr Samer Al-Diri

August 20, 2026 • Healthcare information • Healthcare Management • Healthcare Transformation

From Approval to Accountability: What the FDA’s Discussion Paper on Generative AI-Enabled Medical Devices Could Mean for Healthcare Governance

Evidence in Context The FDA’s new consultation is not yet guidance. Its deeper significance is that safe generative AI in medicine...

Read More →

Dr. Samer Al-Diri is a UK-trained ophthalmologist, public-health professional and strategic healthcare consultant. His work spans healthcare management, health-system transformation, clinical governance, prevention, responsible digital health and eye health.

↑

Close